Fund Holdings

Decheng Capital LLC

Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
CG ONCOLOGY INC(CGON)6,371,6696,371,6690264,551,697431,234,55865.21%+166,682,861
Aclaris Therapeutics, Inc.4,041,7364,041,736012,165,62515,156,5102.29%+2,990,885
Equillium Inc.4,447,3084,447,30806,893,3288,894,6161.34%+2,001,288
Zentalis Pharmaceuticals Inc.1,323,3271,323,32701,786,4913,096,5850.47%+1,310,094
Pyxis Oncology, Inc (formerly Apexigen)326,810326,8100375,832477,1430.07%+101,311
BeyondSpring Inc.3,800,7023,800,70206,195,1456,233,1520.94%+38,007
REZOLUTE INC59,9000-59,900141,3640-141,364
Nuvation Bio Inc.(NUVB)646,0570-646,057213,1980-213,198
4D MOLECULAR THERAPEUTICS IN44,3110-44,311332,3330-332,333
Aura Biosciences, Inc.360,4830-360,4831,964,6320-1,964,632
KRYSTAL BIOTECH INC(KRYS)17,3007,300-10,0004,265,1421,885,7360.29%-2,379,406
Arcus Biosciences, Inc(RCUS)541,559477,819-63,74012,905,35110,320,8901.56%-2,584,461
CRINETICS PHARMACEUTICALS IN(CRNX)92,7000-92,7004,315,1850-4,315,185
REVOLUTION MEDICINES INC(NSM)(RVMD)200,00093,500-106,50015,930,0009,092,8751.37%-6,837,125
Lyell Immunopharma, Inc.692,050692,050021,301,29913,882,5232.10%-7,418,776
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
592,057325,057-267,00020,769,36010,405,0751.57%-10,364,285
AARDVARK THERAPEUTICS INC3,917,2993,917,299051,414,55014,768,2172.23%-36,646,333
Upstream Bio Inc.3,143,0782,724,868-418,21085,334,56824,523,8123.71%-60,810,756
Nuvation Bio Inc.(NUVB)25,954,43925,954,4390232,551,773111,344,54316.84%-121,207,230
Page 1 of 1